RT Journal Article
SR Electronic
T1 Oral Progesterone Treatment in a Young Woman With Müllerian Adenosarcoma Whose Ovary Was Preserved: A Case Report
JF International Journal of Gynecologic Cancer
JO Int J Gynecol Cancer
FD BMJ Publishing Group Ltd
SP 1222-1224
OP 1222-1224
DO 10.1111/IGC.0b013e3181a84062
VO 20
IS 7
A1 Sung Jong Lee
A1 Jeong-Hoon Bae
A1 Dong Chul Kim
A1 Jong Sup Park
A1 Sung Eun Namkoong
YR 2010
UL http://ijgc.bmj.com/content/20/7/1222-1224.abstract
AB Müllerian adenosarcoma is a rare biphasic tumor in young women. These tumors can recur even after complete resection. We present a patient treated with oral progesterone after hysterectomy with ovary conservation. A 35-year-old woman had a diagnosis of adenosarcoma on hysteroscopic resection, which was estrogen and progesterone receptor positive. She underwent total hysterectomy with ovary conservation and has received oral medroxyprogesterone acetate treatment. At 15 months after surgery, there has been no disease recurrence. Oral medroxyprogesterone acetate therapy can be used effectively in young women with müllerian adenosarcoma whose ovaries are preserved.